HIPAA (Health Insurance Portability and Accountability Act) was signed into law on August 21, 1996, Public Law 104-191. This law was designed to provide insurance portability, to improve the efficiency of health care by standardizing the exchange of administrative and financial data, and to protect the privacy, confidentiality and security of health care information. It impacts all areas of the health care industry.
Electronic Prescribing applications created and sold by Daw Systems, Inc. have been reviewed in order to determine how to best assist our customers with their HIPAA readiness issues. Daw Systems, Inc. has taken all reasonable and industry standard steps to ensure compliance with HIPAA standards.
D.A.W. Systems, Inc. may at times have a need to use and disclose patient information which is governed by the rules and regulations established under HIPAA, the Health Insurance Portability and Accountability Act of 1996, and related policies and procedures of D.A.W. Systems, Inc. Therefore, with regard to patient information, D.A.W. Systems, Inc. commits to the following obligations:
All workforce members of D.A.W. Systems, Inc. who become aware of or suspect any unauthorized use or disclosure of protected health information (PHI), or a breach in the security of a computerized system containing such information, shall be responsible for reporting such unauthorized access or breach to their supervisor or to the designated Security and Privacy Officer.
Below are the details of the policies and procedures in the event of potential or actual breach of Unsecured PHI:
Even if you believe that no ePHI or PHI was compromised, you must notify the Security and Privacy Officer if you believe that any type of sensitive data was compromised. You must also promptly notify your immediate supervisor if any physical or information asset is damaged.
The Security and Privacy Officer shall appropriately document the Risk Assessment and make a recommendation to the President and CEO whether notification to the Covered Entity of the potential breach would be prudent. A written record of an action, activity, or assessment that is required by D.A.W. Systems, Inc. security policies to be documented, must be maintained for six (6) years from the date of its creation or the date when it was last in effect whichever is later.
If you have any questions regarding D.A.W. Systems, Inc. processes or HIPAA-readiness issues, please ask your HIPAA question through e-mail. D.A.W. Systems, Inc. is available to enter into any Business Associate Agreements (BAA) for the purpose of HIPAA privacy regulations. To request a HIPAA or BAA information, please email your business name and contact information to:
info@dawsystems.com.
D.A.W. Systems, Inc. (“D.A.W.”) provides electronic prescribing and related data routing services exclusively within the United States. DAW does not offer or market its services to individuals or entities located outside the United States and does not process personal data subject to the European Union’s General Data Protection Regulation (GDPR) or the United Kingdom GDPR.
All data processed by DAW is handled in compliance with applicable United States laws and regulations, including the Health Insurance Portability and Accountability Act of 1996 (HIPAA) and related state privacy statutes. DAW’s data handling practices are governed by its Privacy Policy, Business Associate Agreement (BAA), and other incorporated service terms, which collectively define DAW’s obligations with respect to the collection, use, disclosure, and protection of Protected Health Information (PHI) and other personal data.
D.A.W. Systems, Inc. does not permit obtrusive or disruptive advertising formats such, as pop-up messages, within its applications. However, ScriptSure may display brand awareness banners in designated areas of the application interface. These banners are non-intrusive, and do not interfere with core prescribing workflows or clinical use.
In addition, D.A.W. Systems, Inc. may provide links to pharmaceutical websites, coupon services, or educational resources intended for use by physicians or patients. Access to such content requires affirmative user action, such as clicking a link, and will never obstruct or delay the functionality of the software.
It is DAW policy not to influence prescribing decisions of an end users. DAW software may provide a great deal of information on all medications and as pertains to the insurance formulary as received by SureScripts. DAW will not encourage/influence prescribing decisions that exceed formulary, benefit, or any other treatment-based information.
The software may present formulary information on-screen; this is for informational purposes only and to assist and not influence the prescriber with prescribing for a particular patient. Furthermore, DAW does not message a patient or prescriber about the benefits of medications over another. All medications are given the same treatment throughout the software.
Sometimes pharma will provide a coupon to give to a patient. This is a dynamic print and there is no indication on-screen as to the existence of the coupon prior to printing or sending the prescription electronically.
The links in this web site will allow you to leave Daw Systems, Inc.’s website. The linked sites are NOT under the control of D.A.W. Systems, Inc., and D.A.W. Systems, Inc. is not responsible for the contents of any linked site or any link contained in any linked site. D.A.W. Systems, Inc. is not responsible for any changes or updates to such sites.
D.A.W. Systems, Inc. provides these links to you solely as a convenience. The inclusion of any link does not constitute nor imply endorsement by D.A.W. Systems, Inc. of the linked site.
The clinical information contained in the Licensed Products is intended as a supplement to, and not a substitute for, the knowledge, expertise, skill, and judgment of physicians, pharmacists, or other healthcare professionals in patient care. The absence of a warning for a given drug or drug combination should not be construed to indicate that the drug or drug combination is safe, appropriate or effective in any given patient.
For purposes of this section, electronic data interchange (EDI) partner means any third-party organization, vendor, or system integrator authorized to electronically exchange data with D.A.W. Systems, Inc. through a certified interface. This includes, but is not limited to, electronic health record systems, practice management systems, pharmacy management systems, veterinary platforms, or other software applications that send or receive prescription-related transactions using D.A.W. Systems, Inc.’s network or hosted services.
End user means an individual who is authorized by an EDI partner or directly by D.A.W. Systems, Inc. to access and use the services for purposes permitted under the applicable agreement, including but not limited to licensed healthcare professionals, administrative staff, or pharmacy personnel. End users may interact with the services via an EDI partner platform or directly through D.A.W. Systems, Inc.’s user interfaces.
D.A.W. Systems, Inc. is not responsible for the availability or uptime of the EDI partner’s systems, the EDI partner’s customers’ systems, or any third-party systems connected through the EDI partner.
D.A.W. Systems, Inc. will log and track all support issues and respond according to severity. D.A.W. Systems, Inc. does not provide support for issues arising from the EDI partner’s own systems or services provided to its end users and will refer such customer cases to the EDI partner to support.
The information presented on this website, in our communications, and in any accompanying materials may include forward-looking statements. These statements relate to our current expectations, projections, plans, goals, and other future events or performance.
Such forward-looking statements are based on assumptions and estimates that involve risks and uncertainties, which are subject to change and may cause actual outcomes to differ materially from those expressed or implied. These risks include, but are not limited to, evolving market conditions, technological developments, regulatory changes, and business execution factors.
DAW Systems, Inc. undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.
The inclusion of such statements on this site or in our materials should not be regarded as a representation that the projected outcomes will be achieved or that we intend to update these statements at any future date.